Kunkel Lori Anne insider trades
Kunkel Lori Anne has filed 21 Form 4s with the SEC that we hold, for Oric Pharmaceuticals, Inc. (ORIC) (Director), Enliven Therapeutics, Inc. (ELVN) (Director), Nurix Therapeutics, Inc. (NRIX) (Director) and Curis INC (CRIS) (Director). Across all of them we count 0 purchases worth $0 and 5 sales worth $850.3K reported on Form 4. In the last 12 months: 0 purchases ($0) and 5 sales ($850.3K). The largest single trade was a sale of 5,889 shares of Enliven Therapeutics, Inc. worth $299.4K, dated 2026-07-06. The first filing on our record is dated 2022-01-31 and the latest 2026-07-08.
Oric Pharmaceuticals, Inc. (ORIC)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Enliven Therapeutics, Inc. (ELVN)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-06-05 | S, sale reported on Form 4 | 354 | $12.7K | 2026-06-09 |
| 2026-06-05 | S, sale reported on Form 4 | 7,779 | $266.7K | 2026-06-09 |
| 2026-06-05 | S, sale reported on Form 4 | 1,867 | $66.0K | 2026-06-09 |
| 2026-07-06 | S, sale reported on Form 4 | 4,111 | $205.5K | 2026-07-08 |
| 2026-07-06 | S, sale reported on Form 4 | 5,889 | $299.4K | 2026-07-08 |
Nurix Therapeutics, Inc. (NRIX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Curis INC (CRIS)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1536368) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms